This is a routine director sale of a small number of shares acquired through vesting. No material impact expected. Monitor for any larger insider sales or changes in insider filing patterns.
LH drugs
LH drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+5- T+0 · Oct 30 $361.39entry
- T+1 · 15d ago −1.60%α −1.13% · $355.59
- T+5 · 11d ago +1.43%α +4.14% · $366.57
- T+11 · todayOpen
- T+20 · in 13d Pending
- T+60 · in 2mo Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Director Richelle P. Parham filed a Form 144 notice of intent to sell 1,078 shares of Labcorp Holdings common stock, with an estimated aggregate market value of approximately $389,395. The sale is planned for October 30, 2026, on the NYSE. The shares were acquired via restricted stock vesting on February 9, 2017, as compensation. The proposed sale represents a very small fraction of the company's $29.2B market cap and is routine for a director.
Key Facts
- Insider: Director Richelle P. Parham
- Proposed sale of 1,078 shares of common stock
- Estimated aggregate value: $389,395.16
- Shares acquired on 02/09/2017 via restricted stock vesting (compensation)
- Proposed sale date: 10/30/2026
- Company market cap: $29.2B
- Shares represent ~0.0013% of shares outstanding (based on market cap and price)
Financial Impact
Proceeds of ~$389,395, which is immaterial relative to the company's $29.2B market cap.
Risk Factors
- Form 144 is an intent to sell; the sale may not be executed.
- No other insider sales or context provided to suggest a broader trend.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001959173-26-007566 |
| Document: 0001959173-26-007566-index.html | 0001959173-26-007566 |
| Document: 0001959173-26-007566.txt | 0001959173-26-007566 |
Track record
29 reports on LH
5 of 5 bullish or bearish reports moved the stock their way by T+5. Best: +17.60% at T+60 after the Apr 30, 2026 report. 5 of 5 went positive at some point.
Filters
- Nov 12, 20264d ago Insider Cluster Neutral 2/10 Entry $372.32 Now $372.46 +0.04% settles Nov 19
- Nov 10, 20266d ago 144 Neutral 2/10 Entry $372.23 Now $372.46 +0.06% settles Nov 18
- Nov 5, 202611d ago Insider Cluster Neutral 2/10 Entry $363.30 to $372.32 Now $372.46 +2.52% ▲ +2.48% −0.81% vs SPY
- Nov 4, 202612d ago 144 Neutral 2/10 Entry $367.79 to $372.23 Now $372.46 +1.27% ▲ +1.21% +2.12% vs SPY
- Nov 4, 202612d ago 8-K Neutral 2/10 Entry $367.79 to $372.23 Now $372.46 +1.27% ▲ +1.21% +2.12% vs SPY
- Nov 3, 202613d ago 144 Neutral 2/10 Entry $353.92 to $370.88 Now $372.46 +5.24% ▲ +4.79% +5.38% vs SPY
- Oct 30, 202617d ago 144 Neutral 2/10 Viewing Entry $361.39 to $366.57 Now $372.46 +3.06% ▲ +1.43% +4.14% vs SPY
- Oct 28, 202619d ago 8-K Bullish 6/10 Entry $360.25 to $367.79 Now $372.46 +3.39% ▲ +2.09% +2.81% vs SPY
- Oct 26, 202621d ago Institutional Cluster Neutral 3/10 Entry $329.90 to $361.39 Now $372.46 +12.90% ▲ +9.55% +10.81% vs SPY
- Oct 21, 202626d ago 8-K Neutral 2/10 Entry $323.75 to $331.17 Now $372.46 +15.05% ▲ +2.29% +2.74% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers